Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.

@article{Ross2006MoxifloxacinVO,
  title={Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.},
  author={Jonathan D. C. Ross and Hendrik S. Cronj{\'e} and Tomasz Paszkowski and Istv{\'a}n R{\'a}k{\'o}czi and D Vildaite and Amar Kureishi and Melody Alefelder and Pierre Arvis and Peter Reimnitz},
  journal={Sexually transmitted infections},
  year={2006},
  volume={82 6},
  pages={446-51}
}
OBJECTIVE This multinational, multicentre, prospective, randomised, double blind, parallel group, non-inferiority study compared the efficacy and safety of moxifloxacin monotherapy with ofloxacin plus metronidazole in women with uncomplicated pelvic inflammatory disease. METHODS Women from hospitals throughout 13 countries received a 14 day course of either oral moxifloxacin, 400 mg once daily (n = 384), or oral ofloxacin, 400 mg twice daily plus oral metronidazole, 500 mg twice daily (n… CONTINUE READING

From This Paper

Topics from this paper.
16 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…